4/24/2014 7:03:13 AM
The CEO of Alexion, the Cheshire-based pharmaceutical company that makes the most expensive drug in the world, received $30.15 million in compensation last year, according to a federal filing Wednesday. Alexion, which developed a biologic drug from CEO Dr. Leonard Bell's Yale research, only has one product so far: Soliris. The drug treats ultra-rare diseases and generally insurers pay more than $400,000 each year for one patient. Patients need it for the rest of their lives.
Help employers find you! Check out all the jobs and post your resume.
comments powered by